My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
01.01.26-12.31.29 Interlocal Agreement between State of Wa and KCPHD (TB)
>
Meetings
>
2026
>
07. July
>
2026-07-07 10:00 AM - Commissioners' Agenda
>
01.01.26-12.31.29 Interlocal Agreement between State of Wa and KCPHD (TB)
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
7/2/2026 12:48:28 PM
Creation date
7/2/2026 12:46:57 PM
Metadata
Fields
Template:
Meeting
Date
7/7/2026
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Resolution to Authorize Execution of an Interlocal Agreement between Kittitas County and the Washington State Department of Health
Order
11
Placement
Consent Agenda
Row ID
146084
Type
Resolution
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
13
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
EXHIBIT A <br />STATEMENT OF WORK <br />Washington State TB Program <br />Kittitas County Public Health <br />DOH Contract Number CLH32635-0 <br />PERIOD OF AGREEMENT: This agreement will commence on January 1, 2026, and will be effective <br />until December 31, 2029, or until the Parties give each other written notice to terminate the agreement. <br />This medication program is ongoing. After the initial three-year period of performance, this agreement will be <br />on a five-year review/renewal cycle but updated/amended as needed based on DOH and/or Health Resources <br />and Services Administration Office of Pharmacy Affairs (HRSA) 340B changing requirements. <br />PURPOSE AND SCOPE: The intent of this agreement is to: <br />• define responsibilities of Parties participating in the HRSA 340B Pricing Program under the DOH <br />TB Program entity. <br />• ensure appropriate use of state taxpayer funds used to acquire tuberculosis (TB) medications. <br />• maintain compliance with HRSA requirements for the 340B Pricing Program entities and those <br />participating under DOH TB Program entity as part of grantee combined purchasing and <br />distribution model for TB medications. <br />• support compliance with HRSA 340B requirements of covered entities. <br />The scope of this agreement covers TB medications used to treat active TB disease in patients who are <br />under- or uninsured or who lack prescription coverage and are not covered by Medicaid or Apple Health. <br />HRSA entities, including LHJs, are expected to be the payer of last resort." <br />o Case -by -case exceptions may be made for Latent TB Infection (LTBI) patients who are likely to <br />progress to TB disease or as announced by DOH. <br />Being the payer of last resort, public health agencies (local, state, or federal) should use their funding only <br />after all reasonable payment sources have been exhausted. <br />DOH TB PROGRAM RESPONSIBILITIES: <br />• Provide without charge TB medications as listed on their current formulary to Local Health <br />Jurisdictions (LHJs). The fonnulary is posted on SharePoint. <br />o DOH will cover the cost of the medication, shipping, and pharmacy. <br />• Annually provide information (example: CDC Notice of Award Number) needed for the LHJ to <br />recertify with HRSA as a federal grantee entity in the 340B program. <br />LOCAL HEALTH RESPONSIBILITIES: Local Health Jurisdictions will: <br />■ Maintain auditable records for the duration identified by required applicable records retention <br />schedules*. These records to include but not limited to are: <br />o a separate medication inventory tracking system with records tied to patients receiving the <br />medication. <br />DOH Contract CLH32635-0 Page 8 of 9 <br />July 2025 <br />
The URL can be used to link to this page
Your browser does not support the video tag.